Clinical trial to evaluate the efficacy of Manjishthadi ointment in management of kikkisa wsr striae gravidarum

An Open Label Randomized Clinical Trial To Evaluate The Efficacy Of Manjishthadi Ointment In Management Of Kikkisa With Special Reference To Striae Gravidarum

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031536

Enrollment

Registered

2021-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O268- Other specified pregnancy relatedconditions

Interventions

Intervention1: Manjishthadi Ointment: Manjishthadi Ointment Local application Twice a day (approx. 10-20gm) from onset of 24 weeks of pregnancy till delivery Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 20-35 years 2. Primipara 3. Women having pregnancy between 24th weeks to till delivry. 4. Patients having classical signs and symptoms of Kikkisa

Exclusion criteria

Exclusion criteria: 1. Age 35 years of age 2. Multiparous females 3. Patient having skin disorders 4. Patient having chronic medical and surgical disorders 5. Any malignancy on the affected part • Patient who are not willing for trial

Design outcomes

Primary

Measure	Time frame
Prevention in formation of Striae gravidarum.Timepoint: 2nd week 4th week 6th week 8th week 10th week 12th week 14th week	—

Secondary

Measure	Time frame
Relief in the Symptoms of Kikkisa i.e. Kandu, Vidaha, VaivarnyataTimepoint: 2nd week 4th week 6th week 8th week 10th week 12th week 14th week	—

Countries

India

Contacts

Public ContactDr Meenakshi Pathak

All India Institute of Ayurveda

sujatadkadam@gmail.com9818294577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026